PF-07264660
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 11
Of
11
Go to page
1
September 26, 2025
A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants
(clinicaltrials.gov)
- P1 | N=12 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed
Trial completion
June 27, 2025
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=340 | Recruiting | Sponsor: Pfizer | Trial primary completion date: Mar 2026 ➔ Jun 2026
Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
April 21, 2025
A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants
(clinicaltrials.gov)
- P1 | N=12 | Active, not recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Active, not recruiting
Enrollment closed
December 02, 2024
A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Pfizer
New P1 trial
October 18, 2024
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=340 | Recruiting | Sponsor: Pfizer | Trial completion date: Feb 2026 ➔ Sep 2026 | Trial primary completion date: Sep 2025 ➔ Mar 2026
Trial completion date • Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
July 12, 2024
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=340 | Recruiting | Sponsor: Pfizer | Trial primary completion date: Feb 2026 ➔ Sep 2025
Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
June 06, 2024
A Preliminary Study to Evaluate PF-07264660 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=59 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed
Trial completion
February 16, 2024
A Preliminary Study to Evaluate PF-07264660 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=59 | Active, not recruiting | Sponsor: Pfizer | Trial completion date: Jan 2025 ➔ Jul 2024 | Trial primary completion date: Jan 2025 ➔ Jul 2024
Trial completion date • Trial primary completion date
August 29, 2023
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=340 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
August 16, 2023
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=340 | Not yet recruiting | Sponsor: Pfizer
New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
July 20, 2023
A Preliminary Study to Evaluate PF-07264660 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=46 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting | N=75 ➔ 46
Enrollment change • Enrollment closed
1 to 11
Of
11
Go to page
1